• Component Description
• Eligible Sample
• Description of Laboratory Methodology
• Laboratory Method Files
• Laboratory Quality Assurance and Monitoring
• Data Processing and Editing
• Analytic Notes
• References
• Codebook
  • SEQN - Respondent sequence number
  • WTSA2YR - Subsample A weights
  • URXUCR - Creatinine, urine (mg/dL)
  • URXUAS3 - Urinary Arsenous acid (ug/L)
  • URDUA3LC - Urinary Arsenous acid comment code
  • URXUAS5 - Urinary Arsenic acid (ug/L)
  • URDUA5LC - Urinary Arsenic acid comment code
  • URXUAB - Urinary Arsenobetaine (ug/L)
  • URDUABLC - Urinary Arsenobetaine comment code
  • URXUAC - Urinary Arsenocholine (ug/L)
  • URDUACLC - Urinary Arsenocholine comment code
  • URXUDMA - Urinary Dimethylarsinic acid (ug/L)
  • URDUDALC - Urinary Dimethylarsinic acid comment cod
  • URXUMMA - Urinary Monomethylarsonic acid (ug/L)
  • URDUMMAL - Urinary MMA acid comment code

National Health and Nutrition Examination Survey

2013-2014 Data Documentation, Codebook, and Frequencies

Arsenics - Speciated - Urine (UAS_H)

Data File: UAS_H.xpt

First Published: January 2016

Last Revised: NA

Component Description

Arsenic is widely distributed in the earth’s crust and is found most often in ground water rather than surface water. People encounter arsenic in many chemical forms that vary greatly in toxicity. The most toxic of the naturally-occurring arsenic compounds are inorganic forms of arsenic and their methylated metabolites. Less toxic are the organic arsenic compounds.

Eligible Sample

Examined participants aged 6 years and older from a one-third sample were eligible.

Description of Laboratory Methodology

Arsenobetaine, arsenocholine, monomethylarsonic acid, dimethylarsinic acid, arsenous (III) acid, arsenic (V) acid

The concentration of speciated arsenics is determined by using high performance liquid chromatography (HPLC) to separate the species coupled to an ICP-DRC-MS to detect the arsenic species. This analytical technique is based on separation by anion-exchange chromatography (IC), followed by detection using quadrupole ICP-MS technology, and includes DRC™ technology (Baranov VI et al., 1999), which minimizes or eliminates many argon-based polyatomic interferences (Tanner S et al., 2000) will require 0.5 mL of urine. Arsenic species column separation is largely achieved due to differences in charge-charge interactions of each negatively-charged arsenic component in the mobile phase, with the positively-charged quaternary ammonium groups bound at the column’s solid-liquid interface. Upon exit from the column, the chromatographic eluent goes through a nebulizer, where it is converted into an aerosol upon entering the spray chamber.

Carried by a stream of argon gas, a portion of the aerosol is transported through the spray chamber and then through the central channel of the plasma, where it is heated to temperatures of 6000-8000° K. This thermal energy atomizes and ionizes the sample. The ions and the argon enter the mass spectrometer through an interface that separates the ICP, which is operating at atmospheric pressure (approximately 760 torr), from the mass spectrometer, which is operating at approximately 10^-5 torr.

The mass spectrometer permits detection of ions at each mass-to-charge ratio in rapid sequence, which allows the determination of individual isotopes of an element. Once inside the mass spectrometer, the ions pass through the ion optics, then through the DRC™, and finally through the mass-analyzing quadrupole before being detected as they strike the surface of the detector. The ion optics uses an electrical field to focus the ion beam into the DRC™.

The DRC™ component is pressurized with an appropriate reaction gas and contains a quadrupole. In the DRC™, elimination or reduction of argon-based polyatomic interferences takes place through the interaction of the reaction gas with the interfering polyatomic species in the incoming ion beam. The quadrupole in the DRC™ allows elimination of unwanted reaction by-products that would otherwise react to form new interferences.

Refer to the Laboratory Method Files section for detailed laboratory procedure manual(s) of the methods used.

There were no changes to the lab method, lab equipment, or lab site for this component in the NHANES 2013-2014 cycle.

Laboratory Method Files

Arsenobetaine, Arsenocholine, Trimethylarsine Oxide, Monomethylarsonic Acid, Dimethylarsinic Acid, Arsenous (III) Acid, Arsenic (V) Acid (January 2016)

Laboratory Quality Assurance and Monitoring

Urine specimens are processed, stored, and shipped to the Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA for analysis.

Detailed instructions on specimen collection and processing are discussed in the NHANES Laboratory Procedures Manual (LPM). Vials are stored under appropriate frozen (–70°C) conditions until they are shipped to National Center for Environmental Health for testing.

The NHANES quality assurance and quality control (QA/QC) protocols meet the 1988 Clinical Laboratory Improvement Amendments mandates. Detailed QA/QC instructions are discussed in the NHANES LPM.

Mobile Examination Centers (MECs)

Laboratory team performance is monitored using several techniques. NCHS and contract consultants use a structured quality assurance evaluation during unscheduled visits to evaluate both the quality of the laboratory work and the quality-control procedures. Each laboratory staff member is observed for equipment operation, specimen collection and preparation; testing procedures and constructive feedback are given to each staff member. Formal retraining sessions are conducted annually to ensure that required skill levels were maintained.

Analytical Laboratories

NHANES uses several methods to monitor the quality of the analyses performed by the contract laboratories. In the MEC, these methods include performing blind split samples collected on “dry run” sessions. In addition, contract laboratories randomly perform repeat testing on 2% of all specimens.

NCHS developed and distributed a quality control protocol for all the contract laboratories which outlined the use of Westgard rules (Westgard et al, 1981) when running NHANES specimens. Progress reports containing any problems encountered during shipping or receipt of specimens, summary statistics for each control pool, QC graphs, instrument calibration, reagents, and any special considerations are submitted to NCHS quarterly. The reports are reviewed for trends or shifts in the data. The laboratories are required to explain any identified areas of concern.

All QC procedures recommended by the manufacturers were followed. Reported results for all assays meet the Division of Laboratory Sciences’ quality control and quality assurance performance criteria for accuracy and precision, similar to the Westgard rules (Caudill et al, 2008).

Data Processing and Editing

The data were reviewed. Incomplete data or improbable values were sent to the performing laboratory for confirmation.

Analytic Notes

Refer to the 2013-2014 Laboratory Data Overview for general information on NHANES laboratory data.

Subsample Weights

Urinary speciated arsenics were obtained in a one-third subsample of persons 6 years and older. Special sample weights are required to analyze these data properly. Specific sample weights for this subsample are included in this data file and should be used when analyzing these data.

Demographic and Other Related Variables

The analysis of NHANES laboratory data must be conducted using the appropriate survey design and demographic variables. The NHANES 2013-2014 Demographics File contains demographic data, health indicators, and other related information collected during household interviews as well as the sample design variables. The recommended procedure for variance estimation requires use of stratum and PSU variables (SDMVSTRA and SDMVPSU, respectively) in the demographic data file.

This laboratory data file can be linked to the other NHANES data files using the unique survey participant identifier (i.e., SEQN).

Detection Limits

The detection limits were constant for all of the analytes in the data set. Two variables are provided for each of these analytes. The variable name ending in “LC” (ex., URDUASLC) indicates whether the result was below the limit of detection: the value “0” means that the result was at or above the limit of detection, “1” indicates that the result was below the limit of detection. For analytes with analytic results below the lower limit of detection (ex., URDUASLC=1), an imputed fill value was placed in the analyte results field. This value is the lower limit of detection divided by the square root of 2 (LLOD/sqrt [2]). The other variable prefixed URX (ex., URXUAS) provides the analytic result for that analyte.

The lower limit of detection (LLOD, in µg/L) for the speciated arsenics are:

Variable Name	SAS Label	LLOD
URXUAS3	Urinary Arsenous Acid	0.12
URXUAS5	Urinary Arsenic acid	0.79
URXUAB	Urinary Arsenobetaine	1.16
URXUAC	Urinary Arsenocholine	0.11
URXUDMA	Urinary Dimethylarsinic Acid	1.91
URXUMMA	Urinary Monomethylarsonic Acid	0.20

Please refer to the NHANES Analytic Guidelines and the on-line NHANES Tutorial for further details on the use of sample weights and other analytic issues.

References

• Baranov VI, Tanner SD. A dynamic reaction cell for inductively coupled plasma mass spectrometry (ICP-DRC-MS). Part 1. The rf-field energy contribution in thermodynamics of ion-molecule reactions. J. Anal. At. Spectrom. 1999; 14:1133-1142.
• Caudill S.P., Schleicher R.L., Pirkle J.L. Multi-rule quality control for the age-related eye disease study. Statist. Med. (2008) 27(20:4094-40106.
• Date AR, Gray AL. Applications of inductively coupled plasma-mass spectrometry. New York: Chapman and Hall; 1989.
• Neubauer K. Vollkopf U. The benefits of a DRC™ to remove carbon- and chloride-based spectral interferences by ICP-MS. Atomic Spectroscopy 1999; 20(2):64-8.
• Tanner S, Baranov VI, Vollkopf U. A dynamic reaction cell for inductively coupled plasma mass spectroscopy (ICP-DRC-MS). Part III. Optimization and analytical performance. J. Anal. At. Spectrom. 2000;15:1261-1269.
• Tanner SD, Baranov VI. Theory, design and operation of a DRC™ for ICP-MS. Atomic Spectroscopy 1999; 20(2):45-52.
• Vahter ME. Arsenic. In: Clarkson T W, Friberg L, Nordberg G F, Sager P R, editors. Biological monitoring of toxic metals. New York: Plenum Press, 1988. p.303-21.
• Westgard J.O., Barry P., Hunt M.R., Groth T. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem (1981) 27:493-501.

Codebook and Frequencies